Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cis-diammine(1,1-cyclobutanedicarboxylate)platinum(ii)
2. Diammine(1,1-cyclobutanedicarboxylate)platinum(ii)
1. 0kc57i4unb
2. Azane, 1-carboxycyclobutane-1-carboxylate, Platinum(2+)
3. 287402-09-9
4. Platinum(2+) 1-carboxycyclobutanecarboxylate Ammoniate (1:2:2)
5. Unii-0kc57i4unb
6. Dicycloplatin [who-dd]
7. 1,1-cyclobutanedicarboxylic Acid, Compd. With (sp-4-2)-diammine(1,1-cyclobutanedi(carboxylato-kappao)(2-))platinum (1:1)
8. Platinum, Diammine(1,1-cyclobutanedi(carboxylato-kappao)(2-))-, (sp-4-2)-, 1,1-cyclobutanedicarboxylate (1:1)
9. Platinum, Diammine(1,1-cyclobutanedicarboxylato(2-)-kappao,kappao'')-, (sp-4-2)-, 1,1-cyclobutanedicarboxylate (1:1)
10. Db-119035
11. Cis-diammine(1,1-cyclobutanedicarboxylate)platinum(ii)
12. Q19776556
13. Azane;cyclobutane-1,1-dicarboxylate;cyclobutane-1,1-dicarboxylic Acid;platinum(2+)
14. 1,1-cyclobutanedicarboxylic Acid, Compd. With (sp-4-2)-diammine(1,1-cyclobutanedi(carboxylato-.kappa.o)(2-))platinum (1:1)
15. Platinum, Diammine(1,1-cyclobutanedi(carboxylato-.kappa.o)(2-))-, (sp-4-2)-, 1,1-cyclobutanedicarboxylate (1:1)
16. Platinum, Diammine(1,1-cyclobutanedicarboxylato(2-)-.kappa.o,.kappa.o'')-, (sp-4-2)-, 1,1-cyclobutanedicarboxylate (1:1)
| Molecular Weight | 515.38 g/mol |
|---|---|
| Molecular Formula | C12H20N2O8Pt |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 2 |
| Exact Mass | 515.086760 g/mol |
| Monoisotopic Mass | 515.086760 g/mol |
| Topological Polar Surface Area | 157 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 317 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 5 |
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Dicycloplatin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dicycloplatin, including repackagers and relabelers. The FDA regulates Dicycloplatin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dicycloplatin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dicycloplatin supplier is an individual or a company that provides Dicycloplatin active pharmaceutical ingredient (API) or Dicycloplatin finished formulations upon request. The Dicycloplatin suppliers may include Dicycloplatin API manufacturers, exporters, distributors and traders.
Dicycloplatin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dicycloplatin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dicycloplatin GMP manufacturer or Dicycloplatin GMP API supplier for your needs.
A Dicycloplatin CoA (Certificate of Analysis) is a formal document that attests to Dicycloplatin's compliance with Dicycloplatin specifications and serves as a tool for batch-level quality control.
Dicycloplatin CoA mostly includes findings from lab analyses of a specific batch. For each Dicycloplatin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dicycloplatin may be tested according to a variety of international standards, such as European Pharmacopoeia (Dicycloplatin EP), Dicycloplatin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dicycloplatin USP).
LOOKING FOR A SUPPLIER?
